A newly published scientific review highlights growing evidence that obesity and Alzheimer’s disease may share overlapping biological mechanisms that contribute to cognitive decline and neurodegeneration.

The review, titled “From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer’s Disease,” examines how metabolic dysfunction associated with obesity may influence brain health through pathways involving mitochondrial impairment, oxidative stress, inflammation, and disrupted lipid signaling.

Researchers note that both obesity and Alzheimer’s disease are increasing globally as populations age. According to the review, approximately 11% of Americans over age 65 are diagnosed with Alzheimer’s disease, while obesity rates among older adults in the United States nearly doubled between 1988 and 2018.

The paper outlines several biological processes believed to link the two conditions. These include impaired mitochondrial energy production, increased generation of reactive oxygen species (ROS), chronic systemic inflammation, insulin resistance, and dysregulated adipokine signaling from adipose tissue. The review also discusses how obesity-related metabolic disturbances may contribute to hallmark Alzheimer’s pathologies such as amyloid-β aggregation and tau phosphorylation.

Researchers emphasize that adipose tissue acts not only as a fat storage system but also as an endocrine organ capable of influencing central nervous system function. As a result, metabolic dysfunction in peripheral tissues may have direct implications for neurodegenerative vulnerability and cognitive decline.

At the same time, the review acknowledges that epidemiological evidence has not established as strong or direct a relationship between obesity and Alzheimer’s disease as exists between obesity and type 2 diabetes. While excess weight is widely recognized as a primary driver of type 2 Diabetes, many individuals with obesity do not develop Alzheimer’s disease, suggesting that additional genetic, environmental, or age-related factors may influence disease progression.

The findings underscore the importance of further research into the shared metabolic pathways underlying obesity and neurodegeneration, particularly as scientists seek new strategies to prevent age-related cognitive decline.